ReportGem ReportGem

U.S. COMPANY FILING

NORTHROP GRUMMAN CORP /DE/ — Form 8-K filed 2026-07-21

Filed: 2026-07-21Company: NORTHROP GRUMMAN CORP /DE/Ticker: NOCExchange: NYSEForm: 8-KReport period: 2026-07-21SEC accession: 0001133421-26-000033Event: earningsMateriality: 60

Filing text preview

Northrop Grumman filed an 8-K on July 21, 2026, announcing its second quarter 2026 financial results. The report only references the earnings release and does not include specific financial figures.

This preview uses text already stored in ReportGem and does not fetch the document from object storage during SEO generation. Review the internal filing record and the official SEC source before relying on it.

Open filing record

Related research and intelligence

Official SEC filing2026-07-21Why Regeneron (REGN) Is Up 5.4% After FDA Approves Pasatru For Ultra-Rare FOP Therapy2026-08-20FDA Approves Regeneron's (REGN) Pasatru for Ultra-Rare FOP in August 2026; Shares Up 5.4%2026-08-20Nocera Files 8-K Disclosing Material Agreement and Management Changes2026-08-20Sinocell: SCTB10 injection obtains clinical trial approval2026-08-19Sinocell: Subsidiary SCTA02A Injection Gets Clinical Trial Approval2026-08-19Sinocell: Subsidiary SCTB10 Gets Clinical Trial Approval for Hemophilia A2026-08-1910-Q2026-07-21 · 10-Q